Products - Cyprus Market

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
PRIMAQUINE (as Diphosphate)* 7.5 mg, 15 mg Film-coated tablets Well established Antiparasitic (Malaria) YES
SULFADOXINE / PYRIMETHAMINE * 500mg/25 mg Tablets Well established Antiparasitic (Malaria) YES
ESCITALOPRAM 5mg, 10mg, 15mg, 20mg Film-coated tablets Cipralex® (Lundbeck) Antidepressants Q3-2025
VORTIOXETINE* 5mg, 10mg, 15mg, 20mg Film-coated tablets Brintellix® (H. Lundbeck) Antidepressants YES
CLONAZEPAM 0.5mg, 1mg, 2mg Tablets Rivotril® (Roche) Antiepileptics YES
LEVETIRACETAM* 250mg, 500mg, 750mg, 1000mg Film-coated tablets Keppra® (UCB Pharma) Antiepileptics YES
PREGABALIN 25mg, 75mg, 150mg, 300mg Capsules, hard Lyrica® (Pfizer) Antiepileptics YES
RASAGILINE 1mg Tablets Azilect® (Teva) Antiparkinsons drugs YES
SULPIRIDE 50mg, 200mg Tablets Dogmatil® (Sanofi) Dogmatil® (Wockhardt) Yes for Zone II Q2-2025 for Zone IV
DICLOFENAC SODIUM 100mg Prolonged-release tablets Voltaren® R (Novartis) Anti-inflammatory & antirheumatics Q1/Q2-2026

* Available for distribution only.